Detalhe da pesquisa
1.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Lancet Oncol
; 23(12): 1571-1582, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36370716
2.
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients.
Future Oncol
; 16(22): 1629-1637, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32501121
3.
Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
Oncology
; 94 Suppl 1: 29-33, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30041177
4.
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
Future Oncol
; 13(30): 2791-2797, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29182361
5.
Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer.
Mol Cancer
; 20(1): 151, 2021 11 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34839818
6.
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials.
Cancers (Basel)
; 11(11)2019 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31717791
7.
Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis.
In Vivo
; 32(4): 839-842, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29936468
8.
Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.
BMC Cancer
; 6: 42, 2006 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-16504126
9.
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients.
J Interferon Cytokine Res
; 25(3): 144-51, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15767788
10.
A novel Q3034R BRCA2 germline mutation identified in a fallopian tube cancer patient.
Cancer Lett
; 191(2): 211-4, 2003 Mar 10.
Artigo
Inglês
| MEDLINE | ID: mdl-12618335
11.
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial.
Cancer
; 115(20): 4849-56, 2009 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19626652
12.
Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?
Recent Pat Anticancer Drug Discov
; 1(3): 383-96, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18221048